Medical technology firm Smith & Nephew has concluded the acquisition of Swiss optical tracking technology maker Atracsys Sarl in a bid to support its digital surgery system.
Financial terms of the deal, which was announced last month, have not been disclosed.
Intended for use in computer-assisted surgery, Atracsys Sarl’s optical tracking technology will be leveraged by Smith & Nephew for its multi-asset digital surgery and robotics ecosystem.
The medical technology company expects Atracsys’ fusionTrack 500 optical tracking camera to acts as a key technology for its new robotics platform.
Compared to existing tracking technology, the camera is said to enable higher measurement speed and latency performance, minimised procedure times and better accuracy in finer precision surgical tasks such as bone cuts.
Smith & Nephew focuses on providing medical technology solutions across orthopaedics, advanced wound management and sports medicine.
The company’s Orthopaedics & Trauma portfolio includes joint replacement products for knees, hips and shoulders. These comprise implants for hip, knee and shoulder joints, along with ancillary products such as bone cement.
In addition, the Sports Medicine Joint Repair franchise consists of instruments, technologies and implants required for minimally invasive joint surgery.
Smith & Nephew’s portfolio further includes the NAVIO Surgical System with robotics-assisted technology designed to simplify the surgical process. It comes with a handpiece that accurately removes bone as identified by the surgeon.
The device is intended for partial and also total knee replacement procedures.
Atracsys Sarl offers open platform optical navigation and robotic tracking components that can be used in orthopaedics, neurosurgery, spine and dental therapeutic areas.
Following the closing of the acquisition, Smith & Nephew intends to continue serving these markets.